Annual CFF
Summary
- Current Value
- As of today, MRNA annual cash from financing is $56.00M, up +104.07% on
- Historical Performance
- MRNA annual cash from financing is up +106.41% over the past 3 years, and up +7.69% over the past 5 years
- All-Time High Comparison
- MRNA annual cash from financing is currently -97.25% below its historical high of $2.03B set on
- 3-Year Low Comparison
- MRNA annual cash from financing is +101.62% above its 3-year low of -$3.45B reached on an earlier date
- Sector Comparison
- MRNA annual cash from financing is higher than 76.32% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | $56.00M | +104.1% | +106.4% | +7.7% | +1053.7% | |
| Quarterly Cash From Financing | -$1.00M | -109.1% | +99.9% | -103.4% | -1615.2% | |
| TTM Cash From Financing | $9.00M | +118.0% | +100.2% | -99.5% | -14.6% | |
| Price | $39.60 | +12.7% | -79.4% | -68.1% | – | |
| Annual Cash From Operations | -$3.00B | +3.7% | -122.1% | -554.5% | -10000.0% | |
| Annual Cash From Investing | $1.95B | -53.7% | +122.9% | +10000.0% | +10000.0% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | – | |
| Annual Total Debt | $747.00M | -39.9% | -18.4% | +449.5% | +10000.0% | |
| Shares Outstanding | 390.73M | +1.2% | +1.5% | -2.0% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $56.00M | at high | |
| 5Y | $2.03B | N/A | -97.3% |
| All | $2.03B | -97.3% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$3.45B | N/A | +101.6% |
| 5Y | -$3.45B | +101.6% | |
| All | -$3.45B | +101.6% |
Cash From Financing History
FAQ
What is the current annual cash from financing of MRNA?
As of today, MRNA annual cash from financing is $56.00M
What is 1-year change in MRNA annual cash from financing?
MRNA annual cash from financing is up +104.07% year-over-year
What is 3-year change in MRNA annual cash from financing?
MRNA annual cash from financing is up +106.41% over the past 3 years
How far is MRNA annual cash from financing from its all-time high?
MRNA annual cash from financing is currently -97.25% below its historical high of $2.03B set on December 31, 2020
How does MRNA annual cash from financing rank versus sector peers?
MRNA annual cash from financing is higher than 76.32% of companies in Healthcare sector
When is MRNA next annual earnings release?
The next annual earnings release for MRNA is on
Quarterly CFF
Summary
- Current Value
- As of today, MRNA quarterly cash from financing is -$1.00M, down -111.11% on
- Historical Performance
- MRNA quarterly cash from financing is down -109.09% year-over-year, and up +99.90% over the past 3 years
- All-Time High Comparison
- MRNA quarterly cash from financing is currently -100.07% below its historical high of $1.38B set on
- 3-Year Low Comparison
- MRNA quarterly cash from financing is +99.85% above its 3-year low of -$668.00M reached on
- Sector Comparison
- MRNA quarterly cash from financing is higher than 22.23% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$1.00M | -111.1% | -109.1% | +99.9% | -103.4% | |
| Annual Cash From Financing | $56.00M | – | +104.1% | +106.4% | +7.7% | |
| TTM Cash From Financing | $9.00M | -57.1% | +118.0% | +100.2% | -99.5% | |
| Price | $39.60 | +48.1% | +12.7% | -79.4% | -68.1% | |
| Quarterly Cash From Operations | -$847.00M | +7.8% | +45.9% | -436.1% | -194.9% | |
| Quarterly Cash From Investing | $700.00M | +24.1% | -2.9% | -25.9% | +159.4% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $734.00M | -0.9% | -45.8% | -41.8% | +245.8% | |
| Shares Outstanding | 390.73M | – | +1.2% | +1.5% | -2.0% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.00M | -111.1% | |
| 3Y | $34.00M | -102.9% | |
| 5Y | $44.11M | N/A | -102.3% |
| All | $1.38B | -100.1% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.00M | N/A | +66.7% |
| 3Y | -$668.00M | +99.8% | |
| 5Y | -$1.33B | +99.9% | |
| All | -$1.33B | +99.9% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of MRNA?
As of today, MRNA quarterly cash from financing is -$1.00M
What is MRNA quarterly cash from financing most recent change?
MRNA quarterly cash from financing was down -111.11% on September 30, 2025
What is 1-year change in MRNA quarterly cash from financing?
MRNA quarterly cash from financing is down -109.09% year-over-year
How far is MRNA quarterly cash from financing from its all-time high?
MRNA quarterly cash from financing is currently -100.07% below its historical high of $1.38B set on June 30, 2020
How does MRNA quarterly cash from financing rank versus sector peers?
MRNA quarterly cash from financing is higher than 22.23% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM CFF
Summary
- Current Value
- As of today, MRNA TTM cash from financing is $9.00M, down -57.14% on
- Historical Performance
- MRNA TTM cash from financing is up +118.00% year-over-year, and up +100.23% over the past 3 years
- All-Time High Comparison
- MRNA TTM cash from financing is currently -99.56% below its historical high of $2.03B set on
- 3-Year Low Comparison
- MRNA TTM cash from financing is +100.26% above its 3-year low of -$3.45B reached on an earlier date
- Sector Comparison
- MRNA TTM cash from financing is higher than 53.36% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | $9.00M | -57.1% | +118.0% | +100.2% | -99.5% | |
| Annual Cash From Financing | $56.00M | – | +104.1% | +106.4% | +7.7% | |
| Quarterly Cash From Financing | -$1.00M | -111.1% | -109.1% | +99.9% | -103.4% | |
| Price | $39.60 | +48.1% | +12.7% | -79.4% | -68.1% | |
| TTM Cash From Operations | -$1.98B | +26.7% | +38.3% | -129.8% | -397.6% | |
| TTM Cash From Investing | $1.46B | -1.4% | -25.4% | +127.6% | +207.7% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $734.00M | -0.9% | -45.8% | -41.8% | +245.8% | |
| Shares Outstanding | 390.73M | – | +1.2% | +1.5% | -2.0% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $56.00M | N/A | -83.9% |
| 3Y | $56.00M | -83.9% | |
| 5Y | $2.03B | N/A | -99.6% |
| All | $2.03B | -99.6% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.00M | at low | |
| 3Y | -$3.45B | N/A | +100.3% |
| 5Y | -$3.88B | +100.2% | |
| All | -$3.88B | +100.2% |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of MRNA?
As of today, MRNA TTM cash from financing is $9.00M
What is MRNA TTM cash from financing most recent change?
MRNA TTM cash from financing was down -57.14% on September 30, 2025
What is 1-year change in MRNA TTM cash from financing?
MRNA TTM cash from financing is up +118.00% year-over-year
How far is MRNA TTM cash from financing from its all-time high?
MRNA TTM cash from financing is currently -99.56% below its historical high of $2.03B set on December 31, 2020
How does MRNA TTM cash from financing rank versus sector peers?
MRNA TTM cash from financing is higher than 53.36% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
Cash From Financing Formula
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna
